DENTSPLY Sirona Inc(XRAY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 5:00 PM ET (Korea 9/12 06:00)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -2.74 | Insider Own | 0.85% | Shs Outstand | 199.2M | Perf Week | -8.49% |
| Market Cap | 2.09B | Forward P/E | 6.88 | EPS next Y | -0.63% | Insider Trans | 3.15% | Shs Float | 197.7M | Perf Month | -8.33% |
| Enterprise Value | 4.16B | PEG | 4.1 | EPS next Q | 0.32 | Inst Own | 114.81% | Short Float | 11.17% | Perf Quarter | 3.16% |
| Income | -0.55B | P/S | 0.57 | EPS this Y | -4.44% | Inst Trans | 2.67% | Short Ratio | 4.43 | Perf Half Y | -11.36% |
| Sales | 3.64B | P/B | 1.54 | EPS next 5Y | 1.68% | ROA | -9.69% | Short Interest | 22.09M | Perf YTD | -8.49% |
| Book/sh | 6.78 | P/C | 8.72 | EPS past 3/5Y | 12.05% -51.27% | ROE | -32.98% | 52W High | -29.11% ($14.76) | Perf Year | -24.96% |
| Cash/sh | 1.2 | P/FCF | 14.58 | Sales past 3/5Y | -2.1% 1.95% | ROIC | -15.9% | 52W Low | 11.22% ($9.40) | Perf 3Y | -71.4% |
| Dividend Est. | $0.06 (0.61%) | EV/EBITDA | 7.79 | EPS Y/Y TTM | 42.34% | Gross Margin | 49.52% | Volatility(W/M) | 3.36% 3.75% | Perf 5Y | -82.82% |
| Dividend TTM | 0.32 | EV/Sales | 1.14 | Sales Y/Y TTM | -0.76% | Oper. Margin | 5.08% | ATR (14) | 0.47 | Perf 10Y | -82.28% |
| Dividend Ex-Date | 2025/12/26 | Quick Ratio | 1.07 | EPS Q/Q | 181.71% | Profit Margin | -14.99% | RSI (14) | 35.53 | Recom | 2.79 |
| Dividend Gr. 3/5Y | 8.58% 9.86% | Current Ratio | 1.63 | Sales Q/Q | -4.06% | SMA20 | -5.03% ($11.01) | Beta | 0.86 | Target Price | $13.7 |
| Payout | - | Debt/Eq | 1.71 | Earnings | 2026/8/6 | SMA50 | -13.8% ($12.13) | Rel Volume | 0.65 | Prev Close | $10.5 |
| Employees | 14000 | LT Debt/Eq | 1.54 | EPS/Sales Surpr. | 49.43% 0.91% | SMA200 | -10.94% ($11.74) | Avg Volume(3M) | 4.99M | Price | $10.46 |
| IPO | 1987/8/12 | Option/Short | Yes/Yes | Trades | 17387 | Volume | 3,251,658 | Change | -0.38% |
Company
XRAY is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A global dental solutions company that supplies dental medical devices and consumables. It offers a broad portfolio that encompasses dental implants, digital dentistry systems, imaging equipment, orthodontic and prosthetic products, and dental consumables, serving dental practices and dental laboratories worldwide. The company has established itself as a comprehensive dental solutions provider that combines dental equipment with consumables.
Over the past 1 year, on the lower side
29% below its 1-year high.
XRAY has weak earning power
5.08% of revenue is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -4.4% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -71.4% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.61% annually in dividends.
Tap to view numbers
Ownership is about average
Institutions hold 114.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
PRNT 0.05%
CCFE 0.04%
BSMC 0.02%
BTR 0.02%
FFLS 0.02%It ranks #4 in the industry
Based on market cap of $2B.
XRAY $2B PER -
ISRG $131B PER 42.4
BDX $48B PER 53.6
MDLN $43B PER 38.1
FAQ
What kind of company is XRAY?
XRAY belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of XRAY?
The market cap of XRAY is approximately $2.1B, ranking 2,065 within its sector.
Does XRAY pay dividends?
XRAY has a dividend yield of approximately 0.61%, with an annual dividend of $0.06.
What is the 52-week high and low for XRAY?
XRAY has recorded a 52-week high of $14.76 and a low of $9.40.
